Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05110248

Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application

Cross-sectional observational study to improve MRI data acquisition techniques by optimising MRI sequences for multiple organs and assessing the repeatability and reproducibility of multiparametric MRI, in healthy volunteers.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

This will be a cross-sectional, observational study recruiting up to 600 participants designed at improving MRI data acquisition techniques by optimising MRI sequences and assessing different aspects of the repeatability and reproducibility of multiparametric MRI. Participants will be recruited from Perspectum's own volunteer database, PIC Sites, as well as through advertisements on social media platforms (e.g. Facebook, Instagram), Perspectum's website, as well as through charities.

Suitable participants will be invited to attend a screening visit, normally over the telephone, which will involve eConsent process, collection of participant's self-reported medical evaluation to assess eligibility according to the inclusion and exclusion criteria, and demographics. Visit 1 will consist of the collection of basic anthropometric measurements (e.g. height, weight, waist circumference), a medical history, a MRI scan and optional standard clinical reference assessments. Visit 2- 9 will be a repeat of visit 1 tests and an update on the medical history .

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and older
  • Participant is willing and able to give informed consent for participation in the study
  • The participant has a level of English proficiency that allows them to communicate well with the investigator and could comply with study requirements.
  • The participant is willing and able to undergo MRI scan.

Exclusion criteria

  • Any contraindication to magnetic resonance imaging (incl. pregnancy, nonremovable electronic implants including cochlear implants, infusion pumps, and pacemakers, shrapnel injury, severe claustrophobia, allergic reaction to contrast agents)
  • Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study
  • The participant may be excluded where body habitus is likely to make MRI or echocardiography/ultrasound uncomfortable or unlikely to yield analysable images, and BMI more than 40-45

Treatment and study plan

Primary outcomes

  1. Development of MRI sequences

    Time frame: 7 years from study start

    Development of sequences which will be used to collect good quality data on multiple organs across different MRI scanners and to ensure that desirable images are obtained within reasonable amount of time.

Secondary outcomes

  1. Sequence and parameter validation

    Time frame: 7 years from study start

    Validation of a list of sequences and parameter details

  2. Assessment of MRI metric repeatability

    Time frame: 7 years from study start

    Assessment of repeatability of the MRI metrics across 2 separate MRI acquisitions on the same scanner using statistical methods

  3. Assessment of MRI metric reproducibility

    Time frame: 7 years from study start

    Assessment of reproducibility of the MRI metrics in the same participants scanned on separate MRI scanners

  4. Assessment of participant comfort during scan

    Time frame: 7 years from study start

    Assessment of participant comfort during different MRI protocols with participant questionnaires.

  5. Assessment of Standard clinical reference assessment vs MRI

    Time frame: 7 years from study start

    Assessment of agreement between MRI derived measures and standard clinical reference assessments (ultrasound, echocardiography), in the same participants, including repeatability for both methods where applicable.

Study contacts

Contact information is provided by the study sponsor or research team.

Rob Suriano, PhD

CONTACT

[email protected]

Soubera M Rymell, MSc

CONTACT

[email protected]

00447313272482

Sponsors and collaborators

Lead sponsor

Perspectum

Industry

Registry information

Official study title

Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application (RADIUS)

Acronym: RADIUS

Important dates

Study start
2021
Primary completion
2031
Study completion
2031
First posted
Nov 5, 2021
Registry last updated
May 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.